Improvements in health-related quality of life in psoriatic arthritis patients on etanercept: Results from educate, an open-label study of etanercept patients treated by dermatologists - 21/08/11
Ellen Frankel, MD, Clinical Partners, LLC, Cranston, RI, United States; David Fivenson, MD, private practice, Detroit, MI, United States; Elaine Yu, DPharm, MS, Seth R. Stevens, MD, Amgen Inc., Thousand Oaks, CA, United States
Le texte complet de cet article est disponible en PDF. P2765 Dr. Frankel has no conflict of interest. Dr. Fivenson has received funding from Amgen for clinical trials and honoraria for speaking. Research funded by Immunex Corporation, a wholly owned subsidiary of Amgen Inc., and by Wyeth Research |
Vol 52 - N° 3S
P. P188 - mars 2005 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?